# KORRO BIO INC (KRRO)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/KRRO/

- Reporting holders: 4
- Reported value: $18.2K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $10.3K | 1,035 | 0.0% | 9 |
| [Versant Capital Management, Inc](https://holderbook.com/funds/1735057-versant-capital-management-inc/) | $4.8K | 487 | 0.0% | 3 |
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $2.9K | 291 | 0.0% | 3 |
| [CoreCap Advisors, LLC](https://holderbook.com/funds/1902501-corecap-advisors-llc/) | $277 | 28 | 0.0% | 1 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 4 | $18.2K |
| Q2 2026 | 109 | $226.2M |
| Q1 2026 | 101 | $150.6M |
| Q4 2025 | 83 | $68.9M |
| Q3 2025 | 91 | $475.4M |
| Q2 2025 | 71 | $114.9M |
| Q1 2025 | 75 | $169.0M |
| Q4 2024 | 83 | $359.6M |
| Q3 2024 | 70 | $285.7M |
| Q2 2024 | 63 | $285.8M |
| Q1 2024 | 49 | $621.2M |
| Q4 2023 | 39 | $301.8M |